Atorvastatin Calcium
Product Images NDC 53002-2439

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-2439). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

A cumulative incidence line graph comparing Atorvastatin and Placebo over a period of 3.5 years. The vertical axis shows cumulative incidence percentage ranging from 0.0 to 4.0%, while the horizontal axis indicates time in years from 0.0 to 3.5. The Atorvastatin group, indicated by a solid line, exhibits a consistently lower cumulative incidence compared to the Placebo group, indicated by a dashed line. The hazard ratio (HR) is 0.64 with a confidence interval of 0.50 to 0.83, and the p-value is 0.0005.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

A cumulative hazard plot showing time to first primary endpoint over four years of follow-up. It compares placebo and atorvastatin groups, with cumulative hazard percentage on the y-axis and follow-up time in years on the x-axis. The graph includes a hazard ratio (HR=0.63) with confidence interval and p-value (p=0.001).*

FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over time between atorvastatin 10 mg and atorvastatin 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event, from 0 to 0.2. The graph includes a hazard ratio (HR=0.78) with confidence interval (0.69-0.89) and p-value (0.0002).*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical structure of atorvastatin calcium showing its molecular composition including aromatic rings, hydroxyl groups, fluorine atom, and calcium ions with associated water molecules as part of the structure.*

FDA Label Image

Label Image (Lbl530022439)

The label for ATORVASTATIN CALCIUM 10 mg tablets by RPK Pharmaceuticals, Inc. indicates a prescription medication with 100 tablets per container. Directions state to take 1 tablet daily or as directed. The label includes a QR code, barcode, and spaces for patient, prescriber, and clinic details. Expiry and lot number information are shown, along with standard regulatory markings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.